Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Predictors of Persistent Peanut Allergy at Age 5 Years

View source ↗

Summary

This entry reports a clinical trial studying predictors of persistent peanut allergy by age 5, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Manitoba | Conditions: Allergy to Peanut | Status: ENROLLING_BY_INVITATION